Journal
CANCER AND METASTASIS REVIEWS
Volume 36, Issue 3, Pages 525-545Publisher
SPRINGER
DOI: 10.1007/s10555-017-9692-y
Keywords
microRNA; Head and neck squamous cell carcinoma; Expression signature; Antitumor
Categories
Funding
- JSPS KAKENHI [JP17K16893, JP15K10801]
- Grants-in-Aid for Scientific Research [17K11375, 17K16893] Funding Source: KAKEN
Ask authors/readers for more resources
MicroRNAs (miRNAs) are small noncoding RNAs that act as fine-tuners of the post-transcriptional control of protein-coding or noncoding RNAs by repressing translation or cleaving RNA transcripts in a sequence-dependent manner in cells. Accumulating evidence have been indicated that aberrantly expressed miRNAs are deeply involved in human pathogenesis, including cancers. Surprisingly, these small, single-stranded RNAs (18-23 nucleotides) have been shown to function as antitumor or oncogenic RNAs in several types of cancer cells. A single miRNA has regulating hundreds or thousands of different mRNAs, and individual mRNA has been regulated by multiple different miRNAs in normal cells. Therefore, tightly controlled RNA networks can be disrupted by dysregulated of miRNAs in cancer cells. Investigation of novel miRNA-mediated RNA networks in cancer cells could provide new insights in the field of cancer research. In this review, we focus on head and neck squamous cell carcinoma (HNSCC) and discuss current findings of the involvement of aberrantly expressed miRNAs in the pathogenesis of HNSCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available